Literature DB >> 17007926

Scutellaria baicalensis, a herbal medicine: anti-proliferative and apoptotic activity against acute lymphocytic leukemia, lymphoma and myeloma cell lines.

Takashi Kumagai1, Claudia I Müller, Julian C Desmond, Yasufumi Imai, David Heber, H Phillip Koeffler.   

Abstract

Scutellaria baicalensis (S.B.) is a widely used Chinese herbal medicine. We initially investigated its in vitro anti-tumor activities. S.B inhibited the growth of ALL, lymphoma and myeloma cell lines by inducing apoptosis and cell cycle arrest at clinically achievable concentrations. The anti-proliferative effect was associated with mitochondrial damage, modulation of the Bcl family of genes, increased level of the CDK inhibitor p27(KIP1) and decreased level of c-myc oncogene. HPLC analysis of S.B. showed it contains 21% baicalin and further studies confirmed it was the major anti-cancer component of S.B. Thus, Scutellaria baicalensis should be tested in clinical trials for these hematopoietic malignancies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17007926     DOI: 10.1016/j.leukres.2006.08.019

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  37 in total

1.  Readers' and author's responses to "whatever happened to plausibility as the basis for clinical research and practice after EBM and CAM rushed in?".

Authors:  Barry Levine
Journal:  MedGenMed       Date:  2007-06-13

Review 2.  Exploring therapeutic potentials of baicalin and its aglycone baicalein for hematological malignancies.

Authors:  Haijun Chen; Yu Gao; Jianlei Wu; Yingyu Chen; Buyuan Chen; Jianda Hu; Jia Zhou
Journal:  Cancer Lett       Date:  2014-08-13       Impact factor: 8.679

Review 3.  Traditional Chinese medicine and immune regulation.

Authors:  Hong-Di Ma; Yan-Ru Deng; Zhigang Tian; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2013-06       Impact factor: 8.667

4.  Molecular mechanisms of Bombyx batryticatus ethanol extract inducing gastric cancer SGC-7901 cells apoptosis.

Authors:  Jin-Yi Wu; Almutamad Sheikho; He Ma; Tian-Ci Li; Ya-Qi Zhao; Ya-Lin Zhang; Dun Wang
Journal:  Cytotechnology       Date:  2017-05-24       Impact factor: 2.058

5.  Regulation of cytotoxicity and apoptosis-associated pathways contributes to the enhancement of efficacy of cisplatin by baicalein adjuvant in human A549 lung cancer cells.

Authors:  Suparata Kiartivich; Ying Wei; Jiaqi Liu; Rungtip Soiampornkul; Mihui Li; Hongying Zhang; Jingcheng Dong
Journal:  Oncol Lett       Date:  2017-02-16       Impact factor: 2.967

6.  Icaritin induces AML cell apoptosis via the MAPK/ERK and PI3K/AKT signal pathways.

Authors:  Qihui Li; Lei Huai; Cuiping Zhang; Cuicui Wang; Yujjao Jia; Yirui Chen; Pei Yu; Houcai Wang; Qing Rao; Min Wang; Jianxiang Wang
Journal:  Int J Hematol       Date:  2013-04-03       Impact factor: 2.490

7.  Down-regulation of the PI3K/Akt signaling pathway and induction of apoptosis in CA46 Burkitt lymphoma cells by baicalin.

Authors:  Yi Huang; Jianda Hu; Jing Zheng; Jing Li; Tiannan Wei; Zhihong Zheng; Yingyu Chen
Journal:  J Exp Clin Cancer Res       Date:  2012-05-20

8.  Analyzing Cytotoxic and Apoptogenic Properties of Scutellaria litwinowii Root Extract on Cancer Cell Lines.

Authors:  Zahra Tayarani-Najaran; Seyed Ahmad Emami; Javad Asili; Alireza Mirzaei; Seyed Hadi Mousavi
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-09       Impact factor: 2.629

Review 9.  Medicinal Plants with Anti-Leukemic Effects: A Review.

Authors:  Tahani Maher; Raha Ahmad Raus; Djabir Daddiouaissa; Farah Ahmad; Noor Suhana Adzhar; Elda Surhaida Latif; Ferid Abdulhafiz; Arifullah Mohammed
Journal:  Molecules       Date:  2021-05-07       Impact factor: 4.411

10.  A Chinese herbal formula "Gan-Lu-Yin" suppresses vascular smooth muscle cell migration by inhibiting matrix metalloproteinase-2/9 through the PI3K/AKT and ERK signaling pathways.

Authors:  Yi-Chung Chien; Ming-Jyh Sheu; Chieh-Hsi Wu; Wen-Hsin Lin; Ying-Yi Chen; Po-Liang Cheng; Hsu-Chen Cheng
Journal:  BMC Complement Altern Med       Date:  2012-08-24       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.